Macrophage endocytic trafficking of antiretroviral nanoparticles

Irena Kadiu, Ari Nowacek, JoEllyn M McMillan, Howard Eliot Gendelman

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Aim: Nanoformulated antiretroviral therapy can improve drug compliance for people infected with HIV. Additional benefits would include specific drug deliveries to viral reservoirs and reduction in systemic toxicities. Methods: In this article, we describe mechanisms of crystalline antiretroviral nanoparticle (NP) uptake, intracellular trafficking and release in human monocyte-derived macrophages. Results: Following clathrin-dependent endocytosis NPs bypassed lysosomal degradation by sorting from early endosomes to recycling endosome pathways. Disruption of this pathway by siRNAs or brefeldin-A impaired particle release. Proteomic and biological analysis demonstrated that particle recycling was primarily Rab11 regulated. Particles were released intact and retained complete antiretroviral efficacy. Conclusion: These results suggest possible pathways of subcellular transport of antiretroviral nanoformulations that preserve both particle integrity and antiretroviral activities demonstrating the potential utility of this approach for targeted drug delivery.

Original languageEnglish (US)
Pages (from-to)975-994
Number of pages20
JournalNanomedicine
Volume6
Issue number6
DOIs
StatePublished - Aug 1 2011

Fingerprint

trafficking
Macrophages
Nanoparticles
Recycling
Endosomes
recycling
drug
Brefeldin A
Clathrin
Drug delivery
Sorting
Pharmaceutical Preparations
Toxicity
biological analysis
Endocytosis
Crystalline materials
Degradation
Proteomics
proteomics
integrity

Keywords

  • HIV
  • Rab11
  • antiretroviral therapy
  • drug delivery
  • endocytic trafficking
  • homogenization
  • monocyte-derived macrophages
  • nanoformulated antiretroviral drugs
  • recycling endosomes

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)

Cite this

Macrophage endocytic trafficking of antiretroviral nanoparticles. / Kadiu, Irena; Nowacek, Ari; McMillan, JoEllyn M; Gendelman, Howard Eliot.

In: Nanomedicine, Vol. 6, No. 6, 01.08.2011, p. 975-994.

Research output: Contribution to journalArticle

@article{ec73435c6fdb47958d66c95409192482,
title = "Macrophage endocytic trafficking of antiretroviral nanoparticles",
abstract = "Aim: Nanoformulated antiretroviral therapy can improve drug compliance for people infected with HIV. Additional benefits would include specific drug deliveries to viral reservoirs and reduction in systemic toxicities. Methods: In this article, we describe mechanisms of crystalline antiretroviral nanoparticle (NP) uptake, intracellular trafficking and release in human monocyte-derived macrophages. Results: Following clathrin-dependent endocytosis NPs bypassed lysosomal degradation by sorting from early endosomes to recycling endosome pathways. Disruption of this pathway by siRNAs or brefeldin-A impaired particle release. Proteomic and biological analysis demonstrated that particle recycling was primarily Rab11 regulated. Particles were released intact and retained complete antiretroviral efficacy. Conclusion: These results suggest possible pathways of subcellular transport of antiretroviral nanoformulations that preserve both particle integrity and antiretroviral activities demonstrating the potential utility of this approach for targeted drug delivery.",
keywords = "HIV, Rab11, antiretroviral therapy, drug delivery, endocytic trafficking, homogenization, monocyte-derived macrophages, nanoformulated antiretroviral drugs, recycling endosomes",
author = "Irena Kadiu and Ari Nowacek and McMillan, {JoEllyn M} and Gendelman, {Howard Eliot}",
year = "2011",
month = "8",
day = "1",
doi = "10.2217/nnm.11.27",
language = "English (US)",
volume = "6",
pages = "975--994",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Macrophage endocytic trafficking of antiretroviral nanoparticles

AU - Kadiu, Irena

AU - Nowacek, Ari

AU - McMillan, JoEllyn M

AU - Gendelman, Howard Eliot

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Aim: Nanoformulated antiretroviral therapy can improve drug compliance for people infected with HIV. Additional benefits would include specific drug deliveries to viral reservoirs and reduction in systemic toxicities. Methods: In this article, we describe mechanisms of crystalline antiretroviral nanoparticle (NP) uptake, intracellular trafficking and release in human monocyte-derived macrophages. Results: Following clathrin-dependent endocytosis NPs bypassed lysosomal degradation by sorting from early endosomes to recycling endosome pathways. Disruption of this pathway by siRNAs or brefeldin-A impaired particle release. Proteomic and biological analysis demonstrated that particle recycling was primarily Rab11 regulated. Particles were released intact and retained complete antiretroviral efficacy. Conclusion: These results suggest possible pathways of subcellular transport of antiretroviral nanoformulations that preserve both particle integrity and antiretroviral activities demonstrating the potential utility of this approach for targeted drug delivery.

AB - Aim: Nanoformulated antiretroviral therapy can improve drug compliance for people infected with HIV. Additional benefits would include specific drug deliveries to viral reservoirs and reduction in systemic toxicities. Methods: In this article, we describe mechanisms of crystalline antiretroviral nanoparticle (NP) uptake, intracellular trafficking and release in human monocyte-derived macrophages. Results: Following clathrin-dependent endocytosis NPs bypassed lysosomal degradation by sorting from early endosomes to recycling endosome pathways. Disruption of this pathway by siRNAs or brefeldin-A impaired particle release. Proteomic and biological analysis demonstrated that particle recycling was primarily Rab11 regulated. Particles were released intact and retained complete antiretroviral efficacy. Conclusion: These results suggest possible pathways of subcellular transport of antiretroviral nanoformulations that preserve both particle integrity and antiretroviral activities demonstrating the potential utility of this approach for targeted drug delivery.

KW - HIV

KW - Rab11

KW - antiretroviral therapy

KW - drug delivery

KW - endocytic trafficking

KW - homogenization

KW - monocyte-derived macrophages

KW - nanoformulated antiretroviral drugs

KW - recycling endosomes

UR - http://www.scopus.com/inward/record.url?scp=80052295288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052295288&partnerID=8YFLogxK

U2 - 10.2217/nnm.11.27

DO - 10.2217/nnm.11.27

M3 - Article

C2 - 21417829

AN - SCOPUS:80052295288

VL - 6

SP - 975

EP - 994

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 6

ER -